SCHEMBL394653

SCHEMBL394653

Cc1ccc(C)c(C(C)(C)C)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.48
GABRB2 P47870 1/20 0.48
ALDH1A1 P00352 4/20 0.43
CA2 P00918 4/20 0.39
TRPA1 O75762 2/20 0.39
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP1A2 P05177 1/20 0.38
TYR P14679 2/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PTGS1 P23219 3/20 0.35
PTGS2 P35354 3/20 0.35
LMNA P02545 1/20 0.35
ESR1 P03372 1/20 0.34
HSD17B10 Q99714 2/20 0.33
CA1 P00915 2/20 0.33
CYP2D6 P10635 1/20 0.33
HIF1A Q16665 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31597226 1.00 GABRA1 (0.48) GABRA1GABRB2ALDH1A1CA2TRPA1
SCHEMBL1053673 0.85 ESR1 (0.41) GABRA1GABRB2ALDH1A1CA2TRPA1
SCHEMBL4503429 0.85 GABRA1 (0.45) GABRA1GABRB2ALDH1A1CA2TRPA1
SCHEMBL31612514 0.85 GABRA1 (0.45) GABRA1GABRB2ALDH1A1CA2TRPA1
SCHEMBL128936 0.83 GABRA1 (0.54) GABRA1GABRB2ALDH1A1CA2TRPA1
SCHEMBL285281 0.83 GABRA1 (0.54) GABRA1GABRB2ALDH1A1CA2CYP2C9
SCHEMBL38656859 0.83 GABRA1 (0.54) GABRA1GABRB2ALDH1A1CA2TRPA1
SCHEMBL29636322 0.83 GABRA1 (0.54) GABRA1GABRB2ALDH1A1CA2CYP2C9
Potassium SCHEMBL29477979 0.81 GABRA1 (0.52) GABRA1GABRB2ALDH1A1CA2CYP2C9
SCHEMBL29477944 0.81 GABRA1 (0.52) GABRA1GABRB2ALDH1A1CA2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4013379-B1 NO STAINING ANTIPERSPIRANT COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2025-01-08 EP claimed
CN-117186571-B Ageing-resistant PVC colloidal particle and preparation method thereof 广东银豪塑胶制品有限公司 2024-03-29 CN claimed
CN-117186571-A Ageing-resistant PVC colloidal particle and preparation method thereof 广东银豪塑胶制品有限公司 2023-12-08 CN claimed
US-20220257480-A1 AN ANTIPERSPIRANT COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2022-08-18 US claimed
EP-4013379-A1 AN ANTIPERSPIRANT COMPOSITION Unilever IP Holdings B.V. (NL) 2022-06-22 EP claimed
WO-2021028180-A1 AN ANTIPERSPIRANT COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2021-02-18 WO claimed
EP-4013379-B1 NO STAINING ANTIPERSPIRANT COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2025-01-08 EP disclosed
CN-113387055-B Film, method for producing film, and bag 住友化学株式会社 2024-06-07 CN disclosed
CN-117186571-B Ageing-resistant PVC colloidal particle and preparation method thereof 广东银豪塑胶制品有限公司 2024-03-29 CN disclosed
CN-117186571-A Ageing-resistant PVC colloidal particle and preparation method thereof 广东银豪塑胶制品有限公司 2023-12-08 CN disclosed
CN-112724302-B Ethylene-alpha-olefin copolymer, process for producing the same, ethylene resin composition, and film 住友化学株式会社 2023-10-31 CN disclosed
US-11643533-B2 Film, method of producing film, and bag SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-05-09 US disclosed
CN-112638997-B Film and packaging container 住友化学株式会社 2023-04-28 CN disclosed
EP-1275662-A1 MODIFIED PARTICLE, SUPPORT, CATALYST COMPONENT FOR ADDITION POLYMERIZATION, CATALYST FOR ADDITION POLYMERIZATION, AND PROCESS FOR PRODUCING ADDITION POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-01-15 EP disclosed
US-20020143124-A1 Homogeneous type solid catalyst component or homogeneous type solid catalyst, process for production thereof and process for producing addition polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-10-03 US disclosed
US-20020013433-A1 Transition metal compound, catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-01-31 US disclosed
US-20010053832-A1 Olefin polymerization catalyst and process for producing olefin polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-12-20 US disclosed
EP-1153938-A1 CATALYST FOR STEREOREGULAR POLYMERIZATION OF ALPHA-OLEFIN AND PROCESS FOR PRODUCING STEREOREGULAR ALPHA-OLEFIN POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-11-14 EP disclosed
EP-1134234-A1 Olefin polymerization catalyst and process for producing olefin polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-09-19 EP disclosed
EP-1081167-A1 Olefin polymerization catalyst and process for producing olefin polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220257480-A1 AN ANTIPERSPIRANT COMPOSITION CUTA, TYR, DSG1 GABRA1 3028/4885GABRB2 3450/4885ALDH1A1 264/4885
US-20020013433-A1 Transition metal compound, catalyst for addition polymerization, and process for producing addition polymer ASH2L, ARL1, AS3MT GABRA1 1971/4885GABRB2 2903/4885ALDH1A1 3244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.